ArticleRMD open2018

Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.

Desirée van der Heijde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.